119 related articles for article (PubMed ID: 8733245)
1. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
Lourenço DM; Noguti MA; Juliano L
Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
[TBL] [Abstract][Full Text] [Related]
2. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
5. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
Fourrier F; Chopin C; Goudemand J; Hendrycx S; Caron C; Rime A; Marey A; Lestavel P
Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
8. [Thrombin.antithrombin III complex].
Matsuo T; Kario K; Matsuo M
Rinsho Byori; 1991 Jul; 39(7):701-6. PubMed ID: 1920862
[TBL] [Abstract][Full Text] [Related]
9. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
Büller HR; ten Cate JW
Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
[TBL] [Abstract][Full Text] [Related]
10. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
[TBL] [Abstract][Full Text] [Related]
11. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III in Sepsis. New evidences and open questions.
Ostermann H
Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
[TBL] [Abstract][Full Text] [Related]
13. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
14. [A new method for determination of antithrombin III and its diagnostic significance].
Barkagan ZS; Momot AP; Mamaev AN; Makarov VA; Voiushina TL; Nevedrova OA; Shilova AN; Ziablitskaia NK
Klin Lab Diagn; 2004 Jul; (7):18-21. PubMed ID: 15372880
[TBL] [Abstract][Full Text] [Related]
15. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
Ribeiro AA; Lourenço DM; Toledo CF; Noguti MA; Borges DR
Rev Assoc Med Bras (1992); 1997; 43(3):189-94. PubMed ID: 9497544
[TBL] [Abstract][Full Text] [Related]
17. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan.
Iwasaki Y; Ohbe H; Shigemi D; Fushimi K; Yasunaga H
BJOG; 2022 Apr; 129(5):805-811. PubMed ID: 34545675
[TBL] [Abstract][Full Text] [Related]
18. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
19. The effects of triiodothyronine augmentation on antithrombin III levels in sepsis.
Chapital AD; Hendrick SR; Lloyd L; Pieper D
Am Surg; 2001 Mar; 67(3):253-5; discussion 255-6. PubMed ID: 11270884
[TBL] [Abstract][Full Text] [Related]
20. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]